Abstract
The rate of decline of plasma HIV RNA in patients treated with antiretroviral drugs has been postulated to reflect the half-lives of previously HIV-infected cells. Here, Zvi Grossman and colleagues argue that the observed decline is explained by the kinetics of ongoing infection cycles. Residual cell-to-cell infection that becomes increasingly difficult to block could stabilize cellular provirus reservoirs.
Original language | English |
---|---|
Pages (from-to) | 528-532 |
Number of pages | 5 |
Journal | Immunology Today |
Volume | 19 |
Issue number | 11 |
DOIs | |
State | Published - 1 Nov 1998 |